Regulated Industry Branding Toolkit: Cannabis, Alcohol, Firearms, Supplements, and Fintech

By Casey Scott McKay · 2025-02-04

This toolkit is a guided tour of everything in the Marksy corpus that bears on branding a business whose products are licensed, scheduled, approved, or examined by somebody other than the USPTO. It starts from the one doctrine that reorders the entire filing workflow — that "use in commerce" means lawful use in commerce under 15 U.S.C. sections 1051 and 1127, TMEP 907, and 37 C.F.R. 2.69 — and then works outward through the five sector overlays that decide whether a name can actually launch: TTB certificate of label approval and the geographical indication bar for wine and spirits, ATF marking rules and the National Firearms Act for firearms, FDA and FTC advertising and claim substantiation rules for supplements and cosmetics, state cannabis registries and the November 2026 hemp redefinition, and the money-transmitter, FDIC, FINRA, and SEC Names Rule constraints that make a fintech brand name a compliance instrument rather than a marketing asset. Every cross-referenced document is annotated with what it covers, who it is for, and the point in the matter at which you should reach for it. A branching reading path routes a spirits client, a firearms licensor, a supplement founder, a hemp operator, and a payments startup to different sequences. Closing sections collect the controlling statutes, rules, and cases in a single table, the Marksy templates that apply, and the neighbouring toolkits worth reading next.

IP and Technology > Trademarks | Toolkit | Published 4 February 2025 - Updated 23 November 2025 | Casey Scott McKay - marksy.us

Summary. This toolkit maps the Marksy corpus for anyone branding a business that answers to a regulator other than the USPTO. It begins with the doctrine that governs all of it — that federal registration requires lawful use in commerce — and then works through five sector overlays: TTB label approval and the wine-and-spirits geographical indication bar; ATF marking rules and the National Firearms Act; FDA and FTC claim substantiation for supplements and cosmetics; state cannabis registries and the hemp redefinition that takes effect on 12 November 2026; and the money-transmitter, FDIC, FINRA, and SEC constraints that turn a fintech brand name into a compliance commitment. Every document referenced is annotated with what it covers and when in the matter to reach for it, and a branching reading path routes five different client types through different sequences. Primary authorities, applicable templates, and neighbouring toolkits are collected at the end.

Keywords: regulated industry branding · lawful use requirement · tmep 907 · ttb cola · certificate of label approval · cannabis trademark · hemp cbd trademark · atf marking requirements · nfa suppressor trademark · dietary supplement advertising · ftc substantiation · structure function claim · money transmitter licensing · finra rule 2210 · fdic name misuse · sec names rule · section 2(a) deceptiveness · ancillary trademark portfolio · state trademark registration · regulatory docket

Start Here

Most trademark work assumes one gatekeeper. You clear the name, you file it, an examining attorney decides whether it is confusable or descriptive, and the certificate issues. In regulated industries there are two to four gatekeepers, they apply different tests, and the USPTO is frequently the least demanding of them. A whiskey brand can sail through examination and die at the Alcohol and Tobacco Tax and Trade Bureau. A supplement name can register on the Principal Register and simultaneously constitute an unapproved drug claim. A payments startup can own a federal registration for a word its state licensing regulators will not let it put on a debit card.

Who this is for. Prosecution counsel handed a spirits, firearms, supplement, hemp, or fintech client; in-house counsel building a portfolio inside a licensed business; litigators facing an unlawful-use defense; and founders trying to understand why their lawyer keeps asking for ingredient decks instead of logo files.

The three questions this toolkit answers.

Can this business obtain a federal registration at all, and for which of its goods?
Which regulator, other than the USPTO, has veto power over this name — and on what timetable?
If federal registration is unavailable for the core product, what does the client actually own?

If you read only one thing, read The Lawful Use Requirement. Everything else in this toolkit is an application of it. It explains why illegality is nowhere in 15 U.S.C. § 1052 yet decides thousands of applications a year, what a per se violation is, and why a fully state-licensed cannabis operator is, to the USPTO, a federal criminal enterprise.

One Doctrine, Five Regulators

The rule that reorders the workflow

Section 1 of the Lanham Act requires an applicant to state that the mark "is in use in commerce," 15 U.S.C. § 1051(a)(3)(C), and Section 45 defines that phrase as "the bona fide use of a mark in the ordinary course of trade," 15 U.S.C. § 1127. Since In re Stellar International, Inc., 159 USPQ 48 (T.T.A.B. 1968), the Office has read "ordinary course of trade" to exclude trade Congress has forbidden. The examiner's tool is 37 C.F.R. § 2.69, which permits an inquiry into compliance whenever the sale or transportation of a product is federally regulated, and the operative standard sits in TMEP § 907.

Two consequences follow, and they are the reason regulated-industry filing looks nothing like ordinary filing.

The identification comes before the mark. In a normal matter you pick a name, clear it, then describe the goods. Here you decide what the client may lawfully sell in federal commerce, write that sentence, and only then ask whether a name can be attached to it. A recitation drafted after the branding is locked is a recitation that will have to be amended, and 37 C.F.R. § 2.71(a) permits narrowing but never broadening.

The client's marketing is evidence in the client's own prosecution. Lawfulness is presumed. The presumption falls only where a per se violation appears on the face of the record or a court or competent agency has already found one — the limiting principle of Satinine Societa in Nome Collettivo di S.A. e M. Usellini v. P.A.B. Produits et Appareils de Beaute, 209 USPQ 958 (T.T.A.B. 1981), and In re Midwest Tennis & Track Co., 29 USPQ2d 1386 (T.T.A.B. 1993). The record includes the specimen, the website behind it, the Amazon listing, and the Google Business Profile. In re Morgan Brown, 119 USPQ2d 1350 (T.T.A.B. 2016), refused a facially innocuous "retail store services featuring herbs" recitation because the applicant's own webpage advertised marijuana.

Why these five industries

Cannabis, alcohol, firearms, supplements, and fintech share a structure. In each, a federal statute conditions the sale of the product on a permission the trademark register knows nothing about; in each, a second agency reviews the brand name itself; and in each, the marketing copy that sells the product is simultaneously the evidence that can destroy the registration.

They differ in where the pressure lands. Cannabis and hemp is the only sector where the goods themselves are frequently unlawful — that is a registrability problem. Alcohol is a pre-clearance problem: TTB reviews brand names for misleading content before it issues a certificate of label approval, 27 U.S.C. § 205(e); 27 C.F.R. pt. 13, and a USPTO registration does not bind it. Firearms is a scope and licensing problem: ordinary Class 13 marks register routinely, but recitations reaching National Firearms Act items or export-controlled articles create exposure, and ATF's marking rules complicate brand licensing. Supplements is a claims problem: the name itself can be a drug claim. Fintech is a nomenclature problem: words like "bank," "federal," "insured," and "guaranteed" are regulated vocabulary.

What is genuinely different about fintech

Fintech does not usually fail under TMEP § 907, because payments and lending are lawful activities. It fails somewhere else. Three federal regimes police financial-services names directly. 18 U.S.C. § 709 makes it a crime to use words conveying a false impression of federal agency affiliation in a business name or advertisement. 12 U.S.C. § 1828(a)(4), implemented at 12 C.F.R. pt. 328, subpt. B, prohibits misrepresenting deposit-insurance status or misusing the FDIC name and logo — the provision that produced a wave of FDIC demand letters to neobanks and crypto platforms. And 31 U.S.C. § 333 restricts symbols and names suggesting a Treasury connection.

Layer on the private-sector gatekeepers. A FINRA member firm's new brand campaign is a filing event: retail communications require pre-use approval by a registered principal and, in many categories, submission to FINRA's Advertising Regulation Department, all under content standards requiring that communications be fair, balanced, and free of misleading statements. FINRA Rule 2210. A registered fund's name is a covenant: under the Names Rule, 17 C.F.R. § 270.35d-1, as amended in September 2023, a name suggesting a focus on a particular type of investment obliges the fund to adopt an 80% investment policy. Rebranding a fund is therefore a portfolio decision.

And the lawful-use doctrine does reach fintech at one place. Operating an unlicensed money transmitting business is a federal felony. 18 U.S.C. § 1960. A startup reciting "money transmission services" while holding licenses in eleven of the forty-plus states that require one is not going to draw a § 907 refusal — nothing on the face of the application shows it — but it has handed a future cancellation petitioner or Lanham Act defendant the CreAgri argument. CreAgri, Inc. v. USANA Health Sciences, Inc., 474 F.3d 626 (9th Cir. 2007), stripped a supplement maker of nearly three years of priority because its labels violated FDCA rules. The mark was fine. The compliance was not.

The three failure modes

Nearly every disaster in this practice area is one of three things. Sequencing: the name is chosen, the packaging is printed, and only then does someone ask TTB or FDA. Scope: the identification reaches goods the client cannot lawfully sell, or a class the client filed because it "sounded serious." Docket: the deadline that kills the registration is set by Congress or an agency and never appears in trademark software. Each of the sections below is organized around avoiding one of them.

The Doctrine, and the Two Documents That Execute It

Read the doctrine once, then work from the operational pair. These three are the spine of the cluster.

The Lawful Use Requirement: Why the USPTO Refuses Cannabis, Kratom, and Vape Marks traces the requirement from Stellar through In re Stanley Brothers Social Enterprises, LLC, 2020 USPQ2d 10658 (T.T.A.B. 2020), the Ninth Circuit's delta-8 holding in AK Futures LLC v. Boyd Street Distro, LLC, 35 F.4th 682 (9th Cir. 2022), and the November 2025 federal hemp redefinition. It covers kratom, vapes, alcohol, firearms, tobacco, and gambling in a single frame and closes with four genuinely unsettled questions. Read it before you take the intake call, not after the refusal lands.
Registering a Cannabis-Adjacent Trademark: A Practitioner's Guide to Hemp, CBD, State Registrations, and Ancillary Goods is the fifteen-stage execution manual: client triage, public-record audit, dual clearance, the federal/state/common-law filing map, model identification language for twelve classes, three model office action responses, a sworn answer to a 37 C.F.R. § 2.69 inquiry, and license clauses that avoid dragging the licensor into a state cannabis licensing regime. Reach for it the week you open the file.
Regulated-Industry Trademark Filing Checklist: Cannabis, Alcohol, Firearms, and Supplements is the desk version, extended across all four verticals in eleven phases with form numbers, fee amounts, and a per-SKU verdict memo. Its Phase 1 permit-inventory table and Phase 6 model recitations are the two pages you will photocopy. Use it as the actual working document while the matter is live.

The Identification Is the Whole Case

In ordinary practice the identification is administrative housekeeping. Here it is the substantive legal instrument that decides whether a per se violation appears on the face of the application. Consider Verdant Field Botanicals of Burlington, Vermont, which filed twice on 14 April: VERDANT FIELD for "non-medicated topical body balm containing hemp-derived cannabidiol, said cannabidiol containing less than 0.3% delta-9 tetrahydrocannabinol on a dry weight basis" in Class 3, and VERDANT FIELD for "dietary supplements containing cannabidiol" in Class 5. The first published. The second drew a § 907 refusal citing Stanley Brothers, and no evidence in the world fixes it. Same mark, same company, same day.

The Nice Classification System: Why Your Identification of Goods Decides Your Trademark's Reach explains why 15 U.S.C. § 1112 makes classification irrelevant to registrability while the identification controls the entire relatedness analysis, and why overbroad recitations now invite expungement, reexamination, and post-registration audits. Read it before you write a single recitation for a regulated client.
Drafting an Identification of Goods and Services: A Practitioner's Guide to the ID Manual, Scope, and Amendment supplies the sentence architecture, the ID Manual versus custom-wording decision and its surcharge, restriction language, and the amendment ratchet under 37 C.F.R. § 2.71(a). Its examiner's-amendment-by-phone material is the fastest route out of an indefiniteness requirement on a heavily qualified regulated recitation.
Goods and Services Identification Checklist: Classes, Scope, and Specimen Fit runs the same ground as a tickable eleven-phase procedure, including the specimen-feasibility test that decides whether a class goes in under § 1(a) or § 1(b). Run it on the final recitation set the day before filing.
Pre-Filing Trademark Application Checklist is the short general-purpose confirmation pass — correct legal entity, dates, deadlines, specimens, current fees. It is deliberately generic, so treat it as the last gate after the regulated-industry checklist has done the substantive work.

Trap. Negative limitations are load-bearing. "None containing cannabidiol, kratom, ephedrine alkaloids, or 1,3-dimethylamylamine" converts an ambiguous supplement recitation into one that forecloses the violation on its face. "Non-medicated" does the same work in Class 3. Examiners do not add these words for you.

Cannabis and Hemp: Building a Portfolio Outside the Plant

The plant-touching analysis has not moved since 2016 and will not move on rescheduling alone: Schedule III substances are still controlled substances, and cannabis flower sold at retail without an approved drug application remains an unapproved new drug under 21 U.S.C. § 355(a). What works is a portfolio built entirely off the plant — apparel in Class 25, media and education in Class 41, software in Classes 9 and 42, retail and consulting in Class 35, compliant topicals in Class 3 — plus state registrations wherever the client is licensed. The mechanics are in the cannabis guide above; three companion documents matter here.

Startup and Founder Brand Toolkit: The First Two Years of Trademark Decisions is the sequencing answer when the client can fund three classes rather than eight. Use it in the budget conversation, before you promise a portfolio the company cannot pay for.
Use It or Lose It: Trademark Abandonment, Non-Use, and the Three-Year Presumption is the corrective to token ancillary filings. A hoodie registration supported by $100 of sales and then abandoned is an expungement target under 15 U.S.C. § 1066a and an abandonment claim under § 1127. If you file it, sell it.
Intent-to-Use Applications: Claiming a Trademark Before You Sell a Thing explains the tool that works everywhere except here. In re PharmaCann LLC, 123 USPQ2d 1122 (T.T.A.B. 2017), holds that an applicant cannot possess the bona fide intent § 1051(b) requires where the recited services cannot lawfully be performed. Read it so you can explain to the client why the placeholder filing they read about online is inert.

Alcohol: The COLA Is the Real Clearance

Harrow & Kell Distilling Co. of Louisville cleared HARROW & KELL OLD MERIDIAN for rye whiskey, ordered 40,000 labels, and learned in week nine that TTB would not approve "OLD" on a two-year-old spirit and would not approve "MERIDIAN" alongside imagery implying a Kentucky origin the contract-distilled product did not have. The USPTO had no view on either question. TTB reviews brand names for misleading content before issuing a certificate of label approval under 27 U.S.C. § 205(e) and 27 C.F.R. pt. 13, and it refuses names implying an age, origin, or class the product has not earned.

Three further points shape alcohol filings. First, 15 U.S.C. § 1052(a) bars registration of a geographical indication that, used on wines or spirits, identifies a place other than the origin of the goods — a bar with no secondary-meaning escape. Second, the mandatory Government Warning under 27 U.S.C. § 215 and 27 C.F.R. pt. 16 must appear on the specimen label, and a specimen showing a label TTB never approved is a problem in two agencies at once. Third, TTB's advertising rules impose affirmative content requirements and specific prohibitions on wine and distilled spirits advertising, 27 C.F.R. §§ 4.62, 5.63, and the industry codes administered by DISCUS, the Beer Institute, and the Wine Institute add a 73.6% adult-audience placement standard that no statute requires but every media buyer enforces.

The Section 2 Bars: Surnames, Geography, Deception, and the First Amendment is the doctrinal home for the geographical and deceptiveness refusals that hit spirits brands hardest, including the In re Budge Manufacturing Co., 857 F.2d 773 (Fed. Cir. 1988), deceptiveness test and the materiality requirement of In re California Innovations, Inc., 329 F.3d 1334 (Fed. Cir. 2003). Read it during naming, not during prosecution.
Overcoming a Section 2 Refusal: A Practitioner's Guide to Surname, Geographic, and Deceptiveness Arguments is what you use once the refusal issues — the evidence types, the disclaimer and amendment options, and when to concede. It is the right first stop for a distillery whose founder surname or place name drew a § 2(e) refusal.
Section 2 Refusal Response Checklist: Diagnosis, Evidence, and Filing turns that guide into a filing procedure. Open it the day the office action arrives, because the response window is three months.
Protecting Trade Dress: A Practitioner's Guide to Product Packaging, Product Design, and Registration matters more in alcohol than in almost any other category, because bottle shape, closure, and label architecture carry the brand where the word mark is crowded. Reach for it when the client's differentiator is the package rather than the name.

Firearms: Marking, Scope, and the Licensing Problem

Ordinary Class 13 marks register without incident. The trouble is at the edges. A recitation reading simply "firearms" reaches goods the client cannot lawfully transfer to the public — post-1986 machine guns under 18 U.S.C. § 922(o), undetectable firearms under § 922(p) — and reaches export-controlled articles, since only the January 2020 reclassification moved most commercial firearms, shotguns, and ammunition from the U.S. Munitions List to Commerce Control List entries 0A501, 0A502, and 0A505, effective 9 March 2020. Say what the goods are not: "firearm suppressors; none of the foregoing being machine guns or destructive devices."

The subtler problem is licensing. ATF requires the manufacturer's name and location on the frame or receiver, 27 C.F.R. § 478.92, with a parallel rule for NFA items at § 479.102. When Meridian Arms Co. of Murfreesboro licenses MERIDIAN to a contract manufacturer, the receiver bears the manufacturer's name while the box, the optics, and the apparel bear Meridian's. The regulatory marking and the trademark use diverge, the licensor's inspection rights have to be written against a product it does not make, and five years later somebody argues the license was naked.

Naked Licensing: How Sloppy Quality Control Kills a Trademark explains the abandonment theory and the evidence courts actually credit. Read it before you paper any firearms, spirits, or supplement license, because contract manufacturing is the norm in all three.
Drafting a Trademark License That Survives: A Practitioner's Guide to Quality Control, Scope, and Royalties gives the clause set — standards, inspection, approval workflow, records, termination. Its compensation-structure material is doubly important for cannabis licensors, where a revenue share can trigger state licensure as a true party of interest.
Trademark License Quality Control Checklist: Standards, Inspection, and Recordkeeping is the annual compliance pass that generates the contemporaneous record. Diary it; a quality-control program nobody documented is indistinguishable at trial from one that never existed.

Practice tip. Firearms marketing has its own liability overlay. The Protection of Lawful Commerce in Arms Act, 15 U.S.C. §§ 7901-7903, shields sellers from most suits but excepts knowing statutory violations connected to marketing, and state advertising restrictions are contested — the Ninth Circuit held plaintiffs likely to succeed against California's firearm-advertising restriction in Junior Sports Magazines Inc. v. Bonta, 80 F.4th 1109 (9th Cir. 2023). Brand campaign review is not just a trademark task.

Supplements and Cosmetics: When the Name Is the Claim

Tallgrass Nutrition of Lawrence, Kansas wanted JOINTEASE for a turmeric-and-collagen powder. The USPTO would likely register it over a descriptiveness argument. FDA would read the name as a claim that the product treats a joint condition, which converts a supplement into an unapproved new drug under 21 U.S.C. §§ 321(g)(1)(B) and 355(a). FTC would demand competent and reliable scientific evidence for the implied efficacy claim under 15 U.S.C. §§ 45 and 52 and its Health Products Compliance Guidance. Three regulators, one word.

The rest of the supplement analysis is ingredient-driven. Every dietary ingredient first marketed in the United States on or after 15 October 1994 is a new dietary ingredient requiring premarket notification at least 75 days before introduction, 21 U.S.C. § 350b; a supplement containing an un-notified NDI is adulterated, § 342(f)(1)(B), which is a per se FDCA violation legible from a label. Structure/function claims are permitted with the statutory disclaimer and notice to FDA within 30 days of first marketing, § 343(r)(6). Cosmetics are lighter — no premarket approval, labeling under 21 C.F.R. pt. 701 — but the Modernization of Cosmetics Regulation Act added facility registration and product listing.

Two features of this sector are easy to miss. The first is that your competitor, not the agency, is the likely enforcer: POM Wonderful LLC v. Coca-Cola Co., 573 U.S. 102 (2014), holds that FDCA compliance does not preclude a competitor's Lanham Act false-advertising claim under 15 U.S.C. § 1125(a)(1)(B). The second is a branding paradox — the safest names in this category are the ones that say nothing, and a name that says nothing is a stronger mark anyway. Compliance and distinctiveness point the same direction here, which is rare.

Trademark Clearance Searching: What a Knockout Search Can and Cannot Tell You sets expectations about what screening actually rules out. In regulated sectors, add a second sweep the article does not cover: TTB's public COLA registry, FDA warning letters, and NMLS licensee names.
Running a Full Trademark Clearance Search: A Practitioner's Guide to Screening, Analysis, and the Written Opinion is the method and the opinion structure. Run it on the same calendar as regulatory clearance so both answers arrive before the packaging is designed.
Trademark Clearance Search Checklist: From Knockout to Written Opinion is the tickable version for the associate doing the work.
Specimen Refusals: Why the USPTO Rejected Your Proof of Use covers the four classic failures — mock-ups, webpages without purchase capability, advertising submitted for goods, and mark mismatch — and the substitution strategies. In this sector add a fifth review: read everything else in the frame, because the Supplement Facts panel and the reviews carousel are in evidence too.

Fintech: The Name as a Regulated Instrument

Foldwell, a Charlotte payments startup, launched on a Tuesday with a federal application for FOLDWELL BANK covering "banking services" in Class 36. It is not a bank. It holds money transmitter licenses in nineteen states and partners with a chartered institution for deposit accounts. Four things went wrong at once. The examining attorney issued an information request under 37 C.F.R. § 2.61(b) asking whether the applicant is a chartered depository institution, and the answer sets up a deceptiveness refusal under 15 U.S.C. § 1052(a). Most states prohibit a non-chartered entity from using "bank" in its name at all. The FDIC's rules on misrepresenting insured status, 12 U.S.C. § 1828(a)(4) and 12 C.F.R. pt. 328, subpt. B, reach the marketing that accompanied the name. And every state where Foldwell is licensed needs the consumer-facing brand registered as an assumed name, which is a filing per state, not a footnote.

Fintech naming constraints break into four buckets worth holding in mind.

| Constraint | Source | What it forbids | Practical effect on branding | |---|---|---|---| | Federal-affiliation words | 18 U.S.C. § 709; 31 U.S.C. § 333; 15 U.S.C. § 1052(a), (b) | "National," "Federal," "Reserve," "Treasury," "Deposit Insurance," federal seals and flags, in names or ads implying agency connection | Kills a large share of the trust-signalling names founders love; also a § 2(a)/(b) refusal ground | | Deposit-insurance representations | 12 U.S.C. § 1828(a)(4); 12 C.F.R. pt. 328, subpt. B | Misstating insured status; misusing the FDIC name or logo; obscuring that the fintech itself is not insured | Governs the tagline as much as the mark; pass-through insurance language must be precise | | Chartered-institution nomenclature | State banking codes; entity-formation consent requirements | Non-chartered use of "bank," "banker," "banking," "trust company" | Blocks both the entity name and the Class 36 recitation | | Broker-dealer and fund naming | FINRA Rule 2210; 17 C.F.R. § 270.35d-1; 17 C.F.R. § 275.206(4)-1 | Misleading retail communications; fund names not backed by an 80% policy; unsubstantiated adviser marketing | Makes a rebrand a filing event and, for funds, a portfolio commitment |

Add the unlicensed-money-transmission felony, 18 U.S.C. § 1960, and FinCEN's money services business registration requirement, 31 U.S.C. § 5330 and 31 C.F.R. § 1022.380, and the lawful-use analysis re-enters through the back door in any priority dispute. The CFPB's authority over unfair, deceptive, or abusive acts and practices, 12 U.S.C. § 5531, supplies yet another reviewer of the same sentence.

Choosing a Strong Trademark: The Distinctiveness Spectrum is the naming primer to put in front of a fintech founder who wants TRUSTVAULT FEDERAL. Suggestive and arbitrary names are both stronger marks and cleaner regulatory bets; the descriptive trust-signal names are weak and dangerous.
How to Overcome a Descriptiveness §2(e)(1) Refusal is the fallback when the client insists on the descriptive name anyway. Pair it with an honest estimate of how long acquired distinctiveness will take.
Intent-to-Use Applications earns a second mention here for the opposite reason it failed in cannabis: fintech launches are gated on licensing that takes twelve to twenty-four months, so § 1(b) is the correct basis and the priority date is worth real money.
From Notice of Allowance to Registration: A Practitioner's Guide to Statements of Use and Extension Requests covers the five extensions and the 36-month outside limit — precisely the runway a licensing-gated launch needs. Read it the week the notice of allowance issues.
Statement of Use Filing Checklist: Specimens, Dates, and the Six-Month Clock is the mechanical companion. Diary it against the licensing milestone, not against the marketing plan.

What You Own When You Cannot Register

Federal refusal is not the end of a brand; it is a more fragile and more expensive version of one. State registrations are cheap and real — roughly two dozen states will register cannabis marks, and California created classes 500 and 501 for the purpose — but they create no federal priority. Common-law rights carry a large asterisk after Kiva Health Brands LLC v. Kiva Brands Inc., 402 F. Supp. 3d 877 (N.D. Cal. 2019), which held that federally unlawful use generates no priority a court will credit.

Where Your Trademark Rights End: Tea Rose-Rectanus, Dawn Donut, and the Geography of Common-Law Priority is the doctrinal map: Hanover Star Milling Co. v. Metcalf, 240 U.S. 403 (1916), United Drug Co. v. Theodore Rectanus Co., 248 U.S. 90 (1918), constructive notice under 15 U.S.C. § 1072, and the limited-area defense of § 1115(b)(5). Essential for any multi-state operator whose rights are state-by-state by necessity.
Establishing and Proving Common-Law Trademark Rights: A Practitioner's Guide to Use, Priority, and Territory is the operational companion — fixing the priority date, building an admissible first-use file, and running a market-penetration analysis under Natural Footwear Ltd. v. Hart, Schaffner & Marx, 760 F.2d 1383 (3d Cir. 1985). Use it the moment a competitor appears in a market where you have no registration.
Common-Law Priority Evidence Checklist: Proving First Use and Market Penetration assembles the record in ten phases, including authentication under Fed. R. Evid. 902(11), 902(13), and 902(14). Start it on day one of the dispute, not after the motion is filed.
Cybersquatting and the ACPA and Filing a UDRP Complaint to Recover a Domain matter disproportionately here, because a UDRP panel will usually accept a state registration or demonstrable common-law use as the required trademark right. For a plant-touching operator, the domain is often the only asset it can enforce quickly.
Certification and Collective Marks: Owning a Standard Instead of a Brand and Applying for a Certification or Collective Mark open a route the sector underuses: a trade association can register a compliance standard — third-party-tested hemp, single-estate spirits, verified sourcing — where individual members cannot register the underlying goods.

Prosecution, Maintenance, and the Second Calendar

Office Action Response Toolkit: Refusals, Deadlines, and the Arguments That Work is the general map of refusal types and responses. In this practice area most § 907 responses are amendments rather than arguments; the toolkit helps you tell which is which.
Office Action Response Checklist and The 3-Month Office Action Deadline: What It Means for Applicants together cover the mechanics and the clock. Regulated matters generate longer responses and more client sign-off, so start at week two of the three-month window.
Appealing a Final Refusal: Ex Parte Appeals to the TTAB and Beyond and Taking an Ex Parte Appeal are worth reading even when you will not appeal, because no published cannabis refusal has ever gone past the Board and the statutory-footing argument remains untested at the Federal Circuit.
Docketing Deadlines: Never Miss a Renewal is the habit this practice area demands twice over. Put the 12 November 2026 hemp redefinition, NDI notification windows, COLA lead times, and state license renewals in the same docket as the § 8 dates.
Filing a Section 8 Declaration of Continued Use carries a specific warning here: never sign a declaration you cannot support because the goods stopped being lawful. Narrow the identification and file a matching specimen instead.
Trademark Watch Services: What to Monitor should be pointed at the ancillary classes, which are the ones a regulated brand can actually oppose.
Annual Trademark Portfolio Review Checklist reconciles the register against the business once a year — the pass that catches the class the company quietly stopped selling.
Trademark Due Diligence in Mergers and Acquisitions: An IP Buyer's Guide and Trademarks in the Deal: Chain of Title, Security Interests, and the Anti-Assignment-in-Gross Rule are the sell-side reality check. Regulated-industry diligence routinely discovers that the "portfolio" is a state registration and a domain name.

A Suggested Reading Path

Everyone, first. The Lawful Use Requirement, then The Nice Classification System, then Phases 1 and 2 of the Regulated-Industry Trademark Filing Checklist. About ninety minutes, and it will change what you file.

If the client touches the plant. Add Registering a Cannabis-Adjacent Trademark end to end, then Where Your Trademark Rights End and the Common-Law Priority Evidence Checklist, and finish with Use It or Lose It so the ancillary filings are real.

If the client is a distillery, brewery, or winery. Add The Section 2 Bars, then Protecting Trade Dress, and keep the Section 2 Refusal Response Checklist at hand. Do not file until the COLA question is answered.

If the client makes or licenses firearms. Add Naked Licensing, Drafting a Trademark License That Survives, and the Trademark License Quality Control Checklist. Draft the Class 13 exclusions before anything else.

If the client sells supplements or cosmetics. Add Trademark Clearance Searching and Specimen Refusals, and run the claims review on the brand name itself before the search.

If the client is a fintech. Add Choosing a Strong Trademark, From Notice of Allowance to Registration, and the Statement of Use Filing Checklist. File § 1(b), and check the name against the four-bucket table above before the pitch deck goes out.

If a refusal has already issued. Go straight to the Office Action Response Toolkit and the Office Action Response Checklist, then decide amend-or-argue using Stage 9 of the cannabis guide.

Primary Authorities

| Authority | Holding or requirement | |---|---| | 15 U.S.C. §§ 1051, 1127 | Registration requires "use in commerce," defined as bona fide use in the ordinary course of trade — the textual hook for lawful use | | 37 C.F.R. § 2.69; TMEP § 907 | The Office may inquire into compliance where sale is federally regulated; lawfulness is presumed absent a per se violation | | 37 C.F.R. §§ 2.61(b), 2.71(a) | Examiner information requests; identifications may be narrowed but never broadened | | 15 U.S.C. § 1052(a), (b) | Bars deceptive matter, false suggestion of a connection, wine and spirits geographical indications, and government insignia | | In re Budge Mfg. Co., 857 F.2d 773 (Fed. Cir. 1988) | Three-part deceptiveness test: misdescription, plausibility, materiality to the purchasing decision | | In re Cal. Innovations, Inc., 329 F.3d 1334 (Fed. Cir. 2003) | Geographically deceptively misdescriptive refusals require materiality | | In re Morgan Brown, 119 USPQ2d 1350 (T.T.A.B. 2016) | A facially lawful recitation fails where the applicant's own webpage shows unlawful goods | | In re PharmaCann LLC, 123 USPQ2d 1122 (T.T.A.B. 2017) | No bona fide intent to use where the recited services are federally prohibited | | In re Stanley Bros. Soc. Enters., LLC, 2020 USPQ2d 10658 (T.T.A.B. 2020) | CBD supplements violate 21 U.S.C. § 331(ll); Farm Bill compliance is necessary but not sufficient | | AK Futures LLC v. Boyd St. Distro, LLC, 35 F.4th 682 (9th Cir. 2022) | Hemp-derived delta-8 THC falls within 7 U.S.C. § 1639o and supports Lanham Act rights | | CreAgri, Inc. v. USANA Health Scis., Inc., 474 F.3d 626 (9th Cir. 2007) | Only lawful use creates priority; labeling violations voided three years of use | | Kiva Health Brands LLC v. Kiva Brands Inc., 402 F. Supp. 3d 877 (N.D. Cal. 2019) | Federally unlawful state-licensed use generated no priority against a later federal registrant | | 7 U.S.C. § 1639o(1); 21 U.S.C. § 802(16)(B) | Hemp defined as cannabis at or below 0.3% delta-9 THC on a dry weight basis | | 27 U.S.C. § 205(e); 27 C.F.R. pt. 13 | TTB label approval; brand names reviewed for misleading content before a COLA issues | | 27 U.S.C. § 215; 27 C.F.R. pt. 16 | Mandatory Government Warning on alcohol beverage labels | | 27 C.F.R. §§ 4.62, 5.63 | Required content and prohibited statements in wine and distilled spirits advertising | | 18 U.S.C. § 922(o), (p); 26 U.S.C. §§ 5841, 5845 | Post-1986 machine gun transfer ban; undetectable firearms; NFA registration and definitions | | 27 C.F.R. §§ 478.92, 479.102 | ATF marking of frames, receivers, and NFA items with manufacturer name and location | | 15 U.S.C. §§ 7901-7903 | PLCAA immunity, with a predicate exception for knowing statutory violations tied to marketing | | 21 U.S.C. §§ 350b, 342(f)(1)(B) | New dietary ingredient notification 75 days before marketing; un-notified NDI renders a supplement adulterated | | 21 U.S.C. § 343(r)(6) | Structure/function claims permitted with disclaimer and notice to FDA within 30 days | | 21 U.S.C. §§ 321(ff)(3)(B), 331(ll), 355(a) | Drug-exclusion rules for supplements and foods; unapproved new drugs | | 15 U.S.C. §§ 45, 52; 16 C.F.R. pts. 255, 465 | FTC deception and substantiation authority; endorsement and consumer-review rules | | POM Wonderful LLC v. Coca-Cola Co., 573 U.S. 102 (2014) | FDCA compliance does not preclude a competitor's Lanham Act false-advertising claim | | POM Wonderful, LLC v. FTC, 777 F.3d 478 (D.C. Cir. 2015) | Sustained FTC substantiation requirements for disease claims while trimming the remedy | | 18 U.S.C. § 1960; 31 U.S.C. § 5330; 31 C.F.R. § 1022.380 | Unlicensed money transmission is a felony; FinCEN MSB registration required | | 12 U.S.C. § 1828(a)(4); 12 C.F.R. pt. 328, subpt. B | Prohibits misrepresenting FDIC insured status and misusing the FDIC name or logo | | 18 U.S.C. § 709; 31 U.S.C. § 333 | Criminal bars on business names and advertising implying federal agency or Treasury affiliation | | FINRA Rule 2210; 17 C.F.R. §§ 270.35d-1, 275.206(4)-1 | Retail communication approval and filing; fund names require an 80% policy; adviser marketing standards | | Murphy v. NCAA, 584 U.S. 453 (2018) | Struck PASPA, and with it the unlawful-use obstacle to sports wagering marks |

Forms and Templates

Response to Office Action — Template — the shell for a § 907 or § 2.69 response. Keep the sworn compliance statement short and answer only what was asked.
Trademark License Agreement — Template — the starting point for contract-manufacturing and brand-licensing deals in spirits, firearms, and supplements; revise the quality-control article against the licensee's actual regulatory obligations.
Trademark Coexistence Agreement — Template — useful where a state-registered cannabis or hemp brand and a federal registrant have to divide channels rather than territory.
Trademark Cease-and-Desist Letter — Template — write it around what you actually own. A letter that overclaims federal rights you do not have invites a declaratory judgment action.
Request for Extension of Time to File a Statement of Use — Template — the workhorse for licensing-gated launches; five extensions, then the 36-month wall.
Section 8 Declaration — Template — pair it with a fresh legality check on every listed good before signing.
Trademark Portfolio Inventory — Template — add columns for permit numbers, license expirations, and regulatory trigger dates so the two calendars live in one file.

Related Toolkits and Checklists

The Brand Owner's Master Toolkit — the general roadmap this toolkit specializes. Read it first if the client's regulated line is one product among many.
Trademark Refusals and Statutory Bars Toolkit — every refusal ground in one place, which is the right reference when a regulated application draws three refusals at once.
Trademark Clearance and Brand Selection Toolkit — the naming-stage companion; run its process and the regulatory sweep together.
Trade Dress and Product Design Toolkit — for bottles, tins, and dispensers, where the package outlives the word mark.
Trademark Portfolio Management Toolkit — the budgeting and docketing discipline that keeps a multi-class regulated portfolio alive.
Brand Enforcement Toolkit and the Anticounterfeiting and Border Enforcement Toolkit — enforcement options ranked by what rights you hold; note that CBP recordation requires a federal registration, which is exactly what a plant-touching brand lacks.
Online Brand Protection Toolkit — marketplace and platform takedowns, where a state registration number will often satisfy the form.
International Trademark Toolkit — necessary before any regulated brand goes abroad, because export controls and foreign label rules move on their own schedule.